A Study of TQ-B3525 Tablet in the Treatment of Relapsed / Refractory Mantle Cell Lymphoma (MCL)
Clinical trial NCT04398953 · UNKNOWN
Trial details
- NCT number
- NCT04398953
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-20
- Primary completion
- 2021-09-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.